Cargando…

Salidroside provides neuroprotection by modulating microglial polarization after cerebral ischemia

BACKGROUND: Following stroke, microglia can be driven to the “classically activated” pro-inflammatory (M1) phenotype and the “alternatively activated” anti-inflammatory (M2) phenotype. Salidroside (SLDS) is known to inhibit inflammation and to possess protective effects in neurological diseases, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiangrong, Wen, Shaohong, Yan, Feng, Liu, Kuan, Liu, Liqiang, Wang, Lei, Zhao, Shangfeng, Ji, Xunming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807735/
https://www.ncbi.nlm.nih.gov/pubmed/29426336
http://dx.doi.org/10.1186/s12974-018-1081-0
_version_ 1783299332551737344
author Liu, Xiangrong
Wen, Shaohong
Yan, Feng
Liu, Kuan
Liu, Liqiang
Wang, Lei
Zhao, Shangfeng
Ji, Xunming
author_facet Liu, Xiangrong
Wen, Shaohong
Yan, Feng
Liu, Kuan
Liu, Liqiang
Wang, Lei
Zhao, Shangfeng
Ji, Xunming
author_sort Liu, Xiangrong
collection PubMed
description BACKGROUND: Following stroke, microglia can be driven to the “classically activated” pro-inflammatory (M1) phenotype and the “alternatively activated” anti-inflammatory (M2) phenotype. Salidroside (SLDS) is known to inhibit inflammation and to possess protective effects in neurological diseases, but to date, the exact mechanisms involved in these processes after stroke have yet to be elucidated. The purpose of this study was to determine the effects of SLDS on neuroprotection and microglial polarization after stroke. METHODS: Male adult C57/BL6 mice were subjected to focal transient cerebral ischemia followed by intravenous SLDS injection. The optimal dose was determined by evaluation of cerebral infarct volume and neurological functions. RT-PCR and immunostaining were performed to assess microglial polarization. A transwell system and a direct-contact coculture system were used to elucidate the effects of SLDS-induced microglial polarization on oligodendrocyte differentiation and neuronal survival. RESULTS: SLDS significantly reduced cerebral infarction and improved neurological function after cerebral ischemia. SLDS treatment reduced the expression of M1 microglia/macrophage markers and increased the expression of M2 microglia/macrophage markers after stroke and induced primary microglia from M1 phenotype to M2 phenotype. Furthermore, SLDS treatment enhanced microglial phagocytosis and suppressed microglial-derived inflammatory cytokine release. Cocultures of oligodendrocytes and SLDS-treated M1 microglia resulted in increased oligodendrocyte differentiation. Moreover, SLDS protected neurons against oxygen glucose deprivation by promoting microglial M2 polarization. CONCLUSIONS: These data demonstrate that SLDS protects against cerebral ischemia by modulating microglial polarization. An understanding of the mechanisms involved in SLDS-mediated microglial polarization may lead to new therapeutic opportunities after stroke.
format Online
Article
Text
id pubmed-5807735
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58077352018-02-15 Salidroside provides neuroprotection by modulating microglial polarization after cerebral ischemia Liu, Xiangrong Wen, Shaohong Yan, Feng Liu, Kuan Liu, Liqiang Wang, Lei Zhao, Shangfeng Ji, Xunming J Neuroinflammation Research BACKGROUND: Following stroke, microglia can be driven to the “classically activated” pro-inflammatory (M1) phenotype and the “alternatively activated” anti-inflammatory (M2) phenotype. Salidroside (SLDS) is known to inhibit inflammation and to possess protective effects in neurological diseases, but to date, the exact mechanisms involved in these processes after stroke have yet to be elucidated. The purpose of this study was to determine the effects of SLDS on neuroprotection and microglial polarization after stroke. METHODS: Male adult C57/BL6 mice were subjected to focal transient cerebral ischemia followed by intravenous SLDS injection. The optimal dose was determined by evaluation of cerebral infarct volume and neurological functions. RT-PCR and immunostaining were performed to assess microglial polarization. A transwell system and a direct-contact coculture system were used to elucidate the effects of SLDS-induced microglial polarization on oligodendrocyte differentiation and neuronal survival. RESULTS: SLDS significantly reduced cerebral infarction and improved neurological function after cerebral ischemia. SLDS treatment reduced the expression of M1 microglia/macrophage markers and increased the expression of M2 microglia/macrophage markers after stroke and induced primary microglia from M1 phenotype to M2 phenotype. Furthermore, SLDS treatment enhanced microglial phagocytosis and suppressed microglial-derived inflammatory cytokine release. Cocultures of oligodendrocytes and SLDS-treated M1 microglia resulted in increased oligodendrocyte differentiation. Moreover, SLDS protected neurons against oxygen glucose deprivation by promoting microglial M2 polarization. CONCLUSIONS: These data demonstrate that SLDS protects against cerebral ischemia by modulating microglial polarization. An understanding of the mechanisms involved in SLDS-mediated microglial polarization may lead to new therapeutic opportunities after stroke. BioMed Central 2018-02-09 /pmc/articles/PMC5807735/ /pubmed/29426336 http://dx.doi.org/10.1186/s12974-018-1081-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Liu, Xiangrong
Wen, Shaohong
Yan, Feng
Liu, Kuan
Liu, Liqiang
Wang, Lei
Zhao, Shangfeng
Ji, Xunming
Salidroside provides neuroprotection by modulating microglial polarization after cerebral ischemia
title Salidroside provides neuroprotection by modulating microglial polarization after cerebral ischemia
title_full Salidroside provides neuroprotection by modulating microglial polarization after cerebral ischemia
title_fullStr Salidroside provides neuroprotection by modulating microglial polarization after cerebral ischemia
title_full_unstemmed Salidroside provides neuroprotection by modulating microglial polarization after cerebral ischemia
title_short Salidroside provides neuroprotection by modulating microglial polarization after cerebral ischemia
title_sort salidroside provides neuroprotection by modulating microglial polarization after cerebral ischemia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807735/
https://www.ncbi.nlm.nih.gov/pubmed/29426336
http://dx.doi.org/10.1186/s12974-018-1081-0
work_keys_str_mv AT liuxiangrong salidrosideprovidesneuroprotectionbymodulatingmicroglialpolarizationaftercerebralischemia
AT wenshaohong salidrosideprovidesneuroprotectionbymodulatingmicroglialpolarizationaftercerebralischemia
AT yanfeng salidrosideprovidesneuroprotectionbymodulatingmicroglialpolarizationaftercerebralischemia
AT liukuan salidrosideprovidesneuroprotectionbymodulatingmicroglialpolarizationaftercerebralischemia
AT liuliqiang salidrosideprovidesneuroprotectionbymodulatingmicroglialpolarizationaftercerebralischemia
AT wanglei salidrosideprovidesneuroprotectionbymodulatingmicroglialpolarizationaftercerebralischemia
AT zhaoshangfeng salidrosideprovidesneuroprotectionbymodulatingmicroglialpolarizationaftercerebralischemia
AT jixunming salidrosideprovidesneuroprotectionbymodulatingmicroglialpolarizationaftercerebralischemia